Capricor Therapeutics Inc. CAPR
$26.01
▲ +3.04% 24H
About
Capricor Therapeutics Inc. is a clinical-stage biotechnology company focused on developing transformative cell and exosome-based therapeutics for rare diseases with high unmet medical needs, particularly Duchenne muscular dystrophy (DMD), which causes muscle degeneration and premature death. Its lead product candidate,…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees160
TickerCAPR
Statistics
Market Cap$1.50B
Revenue (TTM)$0
Net Income-$105.0M
Net Margin—
EPS$-2.26
P/E-11.08
P/S—
P/B5.24
EV/EBITDA-10.20
ROE-56.4%
Dividend Yield—
Price$26.01
Data: Twelve Data · Revenue = mcap / P/S